Arthritis and Osteoporosis Associates of New Mexico
Las Cruces, New Mexico, United States
Doctor in Las Cruces, New Mexico
1255 Hillrise Cir, Las Cruces, NM 88011
About Arthritis and Osteoporosis Associates of New Mexico
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Eli Lilly and Company
2
Bristol-Myers Squibb
1
Celgene
1
Clinical Trials at Arthritis and Osteoporosis Associates of New Mexico
During the past decade, Arthritis and Osteoporosis Associates of New Mexico conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on
average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis
2009-10-31
2014-01-28
Completed
1,162
A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors
2011-08-02
2016-03-25
Completed
3,080
A Study of the Impact of Methotrexate (MTX) Discontinuation on the Efficacy of Subcutaneous (SC) Tocilizumab (TCZ) With MTX
2013-11-07
2016-10-14
Completed
718
A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus
2017-07-06
2021-08-03
Completed
289
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II)
2018-08-02
2021-10-20
Completed
778
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)
2019-09-09
2022-04-01
Terminated
1,156
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Arthritis and Osteoporosis Associates of New Mexico"
#1 collaborator was "Incyte Corporation" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Arthritis and Osteoporosis Associates of New Mexico
According to Clinical.Site data, the most researched conditions in "Arthritis and Osteoporosis Associates of New Mexico" are
"Rheumatoid Arthritis" (4 trials), "Systemic Lupus Erythematosus" (2 trials) and "Lupus Erythematosus, Systemic" (1 trials). Many other conditions were trialed in "Arthritis and Osteoporosis Associates of New Mexico" in a lesser frequency.
Clinical Trials Intervention Types at Arthritis and Osteoporosis Associates of New Mexico
Most popular intervention types in "Arthritis and Osteoporosis Associates of New Mexico" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Baricitinib" (2 trials), "Placebo" (2 trials), "Tocilizumab" (2 trials), "Abatacept" (1 trials) and "Adalimumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Arthritis and Osteoporosis Associates of New Mexico
The vast majority of trials in "Arthritis and Osteoporosis Associates of New Mexico" are
7 trials for "All" genders.
Clinical Trials Status at Arthritis and Osteoporosis Associates of New Mexico
Currently, there are NaN active trials in "Arthritis and Osteoporosis Associates of New Mexico".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Arthritis and Osteoporosis Associates of New Mexico,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Arthritis and Osteoporosis Associates of New Mexico, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".